Avitas Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-47,064
Closed -$3.75M 206
2024
Q1
$3.75M Buy
47,064
+396
+0.8% +$30.2K 0.57% 44
2023
Q4
$3.68M Buy
46,668
+1,239
+3% +$88.2K 0.62% 42
2023
Q3
$3.17M Sell
45,429
-6,928
-13% -$491K 0.6% 40
2023
Q2
$3.62M Buy
52,357
+11,200
+27% +$797K 0.66% 43
2023
Q1
$3.06M Sell
41,157
-286
-0.7% -$24K 0.6% 46
2022
Q4
$3.86M Buy
41,443
+6,576
+19% +$635K 0.82% 38
2022
Q3
$3.33M Buy
34,867
+283
+0.8% +$28K 0.76% 38
2022
Q2
$3.21M Buy
34,584
+458
+1% +$44.7K 0.7% 41
2022
Q1
$3.45M Sell
34,126
-14,398
-30% -$1.51M 0.62% 50
2021
Q4
$5.01M Buy
48,524
+853
+2% +$78.8K 0.84% 41
2021
Q3
$4.04M Sell
47,671
-202
-0.4% -$16.9K 0.74% 51
2021
Q2
$4M Buy
47,873
+1,270
+3% +$104K 0.71% 51
2021
Q1
$3.51M Buy
46,603
+3,212
+7% +$234K 0.69% 49
2020
Q4
$2.96M Buy
+43,391
New +$2.82M 0.6% 56

Other funds holding CVS

Avitas Wealth Management's CVS Position: Q2 2024 in Review

Avitas Wealth Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 47,064 shares — an estimated $3.75M sold.

Avitas Wealth Management first reported a position in CVS in Q4 2020 and held it in 14 quarters. The position peaked at $5.01M in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Avitas Wealth Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Avitas Wealth Management sold 47,064 CVS Health shares in Q2 2024, an estimated $3.75M.
  • Avitas Wealth Management first reported a position in CVS Health in Q4 2020 and held it in 14 quarters.
  • Avitas Wealth Management's CVS Health position peaked at $5.01M in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Avitas Wealth Management's 13F filing for Q2 2024, filed 24 Jul 2024.